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Summary: Valid indications of a key role for dopaminergic drugs in glycoprotein fucosylation in neuronal
tissue in vitro led us to investigate whether the administration of dopaminergic agonists/antagonists influences
fucose metabolism in the rat brain in vivo. Three test groups were set up. Group 1 was given L-DOPA
(210 mg/1), Group 2 haloperidol (10.5 mg/1) in drinking water, Group 3 served as control. The rats were
sacrificed after 8 weeks and enzyme activities in 5 different brain areas were determined concerning the
enzymes of the anabolic fucose metabolism: fucokinase, fucose-1-phosphate pyrophosphorylase and fucosyl-
transferase 1 and 2. Only the specific activity of fucokinase was affected by haloperidol or L-DOPA
administration. In the olfactory bulbus, thalamus and cortex, haloperidol decreased fucokinase activity by
21%, 37%, and 39%, respectively (p < 0.05 in each case). No changes were observed in the cerebellum and
striatum. Surprisingly, fucokinase activity in the cortex was decreased by L-DOPA (31%, p < 0.05).
Conclusions: Cerebral fucokinase activity is influenced in vivo by dopaminergic drugs in well circumscribed
brain areas. Other enzymes of the anabolic fucose metabolism showed no change in activity. It is, therefore,
conceivable that these drugs, apart from known mechanisms, exert part of their pharmacological action via
a modulation of fucose metabolism.
Introduction , ,
 r . * ·* _ .· /c\ ? ube drawn from experiments with chicks (5). Further-
L-Fucose (like N-acetylneuraminic acid and some- more, fucosylation inhibition by 2-deoxy-D-galactose
times also N-acetyl^D-glucosamine and £>-galactose) (6, 7) caused amnesia in trained rats and chicks (8,
is a terminal sugar of numerous glycoconjugates (1, 9). The cellular mechanisms mediating enhanced fu-
2). Fucosylated glycoproteins are thought to play an cose incorporation in the course of memory formation
essential role in the formation of long-term memory are still poorly understood. It has been shown that
traces in the rat brain (3, 4). A similar conclusion can glycoprotein fucosylation can be stimulated by do-
- pamine receptor agonists in vitro (10). We therefore
j) Enzymes: investigated whether a long-term supply of dopami-
Fucokinase EC 2.7.1.52 nergic agonists/antagonists (L-DOPA and haloperi-
Fucose-l-pbosphate pyrophosphorylase - fucose-1-phos-
 dol) to the rat bfain jn vivo infhiences the activity of
phate gyanylyltransferase; GTP: fucose-1-phosphate gyany- . t^ ** , ,· ,<- *^ * » »
lyltransferase EC 2.7.7.30 key enzymes1) of fucose anabohsm (fig. 1): fucokmase,
Fucosyltransferase 1, GDP-fucose: asialoglycoprotein fuco- fucose-1-phosphate-pyrophosphorylase, GDP-fu-
sykransferase = galactoside 2-oc-L-fucosyltransferase EC cose: asialoglycoprotein fucosyltransferase (fucosyl-
Fucosyltransferase 2, GDP-fucose: asialogalactoglyco- transferase 1) and GDP-fucose: asialoagalactoglyco-
protein fucosyltransferase. protein fucosyltransferase (fucosyltransferase 2).
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Fig. 1. Anabolic L-fucose metabolism in the rat brain. The synthesis of fucosylated glycoproteins starting from the precursor
fructose-6-phosphate seems to be of minor importance in the rat brain.
Materials and Methods
Materials
Unless otherwise stated, all reagents were of analytical grade
and were purchased from Merck (Darmstadt, Germany) and
Sigma (M nchen, Germany). [14C]L-Fucose and GDP-L-
[14C]fucose were from Amersham (Arlington, Great Britain). L-
[l-14C]fucose-l-phosphate was prepared in our laboratory using
GDP-L-[14C]fucose as starting material.
Enzyme assays
Fucokinase assay
Enzyme activity was determined as described earlier (11).
Briefly, the tissue was homogenized in nine volumes of assay
buffer using a Dounce homogenizer, and the homogenate thus
obtained was centrifuged at 40000g for 30 min. The superna-
tant served as a crude enzyme source for the fucokinase (and
for fucose-1-phosphate pyrophosphorylase as well). The reac-
tion mixture contained (in a final volume of 0.15 ml) 5 g/1
Triton X-100, 30 mmol/1 MgCl2, 10 mmol/1 phosphoenolpyru-
vate, pH 7.0,10 mmol/1 ATP, pH 7.0, 0.5 U of pyruvate kinase,
50 mmol/1 Tris-HCl, pH 7.4, 30 mmol/1 NaCl, 20 mmol/1 L-
fucose and 0.4 mol/1 [l4C]L-fucose. The assay was started by
addition of the crude enzyme preparation; after incubation of
37 °C for 20 min, the reaction was stopped by addition of cold
ethanol (970 ml/1). After centrifugation at 20 000 g for 10 min,
an aliquot of the resulting supernatant was applied to Whatman
3 MM paper, and the different fucose metabolites formed were
separated by using the following solvent system: n-propanol/
Na(CH3COO), 1 mol/l/H2O (7 + 1 + 1, by vol.) according to
Levin & Wei(\2).
Fucose-1-phosphate pyrophosphorylase assay
The assay mixture contained (in a final volume of 0.1 ml) 100
mmol/1 Tris-HCl, pH 7.4, 5 mmol/1 MgCl2, 40 mmol/1 nicotinic
acid, 10 g/1 Triton X-100, 10 mmol/1 GTP, 10 mmol/1 fueose-
1-phosphate, and 0.8 μηιοΐ/ΐ L-[l-14C]fucose-l-phosphate. The
reaction was started by addition of the crude enzyme prepa-
ration (as described above). After incubation for 20 min at
37 °C, the reaction was stopped by addition of cold ethanol
(970 ml/1). After centrifugation at 20 000 g for 10 min, the
supernatant was analyzed by paper chromatography using the
following solvent system: C2H5OH/NH3(CH3COO), 1 mol/1(5 + 2, by vol.) (13).
Fucosyltransferase assay
The activity of the GDP-fucose : glycoprotein fucosyltransfer-
ases was determined by measuring the incorporation rate of
[I4C]fucose from the nucleotide sugar GDP-L-[14C]fucose into
desialylated fetuin (fucosyltransferase 1) and desialodegalacto-
fetuin (fucosyltransferase 2). In a final volume of 0.15 ml, the
reaction mixture contained 2 mmol/1 MgCi2, 0.4 mmol/1 ATP,
1.85 kBq (0.05 μ€ί) GDP-L-[14C]fucose, 5 mmol/1 GDP-L-fu-
cose, 0.5 mg acceptor (desialylated fetuin or desialodegalacto-
fetuin), 1.5 g/1 Triton X-100 and 0.1 mg of sample protein from
the homogenate before it was subjected to centrifugation (see
above). The reaction mixture was incubated for 60 min at 37 °C
and pipetted onto filter paper discs that had been mounted on
pins. The discs were air-dried and washed twice for 30 min
each with 100 g/1, with 50 g/1 trichloroacetic acid and then with
ethanol/water, volume fraction 0.5 (14, 15). Radioactivity was
determined by counting the discs in a toluene scintillation
mixture.
Animals
The investigation was performed using male Wistar rats weigh-
ing 200 g. Three test groups were set up. Group 1 was given L-
DOPA (210 mg/1), Group 2 haloperidol (10.5 mg/1) in drinking
water, while Group 3 served as control. Drinking water was
changed every 2 hours to prevent breakdown of the drugs.
After 8 weeks the rats were sacrificed, and the enzymatic activity
of fucokinase, fucose-1-phosphate pyrophosphorylase and
GDP-fucose as well as of glycoprotein fucosyltransferases, were
determined in 5 different areas (olfactory bulbus, striatum,
thalamus, cerebellum and cortex) carefully dissected from the
total brain.
Statistics
All data are reported as χ ± SD and were analysed using
Student's t-test.
Results
Rats treated with haloperidol or L-DOPA showed no
weight loss as compared to controls. Enzyme activity
differed considerably in the various brain areas of
untreated control rats (figs 2-5). Fucose-1-phosphate
pyrophosphorylase activity increased as follows: thal-
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amus < olfactory bulbus = cortex < striatum =
cerebellum (fig. 3). Fucosyltransferase l activity, on
the other hand, was quite similar in the different areas
of the rat brain (fig. 4). Fucosyltransferase 2 activity
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Fig. 2. Effect of haloperidol (H) and L-DOPA (D) administra-
tion on fucokinase activity in different areas of the rat
brain (olfactory bulbus, striatum, thalamus, cerebellum
and cortex) in vivo. Haloperidol selectively inhibited
fucokinase activity in the olfactory bulbus, thalamus
and cortex by 21%, 37%, and 39% respectively
(p < 0.05 in each case). An inhibition of fucokinase
activity was also seen in the cortex under L-DOPA
(p < 0.05). C: control, η = 7 in each group.
* indicates significant changes (p < 0.05).
was clearly elevated in the cerebellum and nearly equal
in the olfactory bulbus, striatum, thalamus and cortex
(fig. 5). Fucokinase activity increased in untreated
rats as follows: thalamus < striatum < olfactory
bulbus = cerebellum = cortex. Fucose-1-phosphate
pyrophosphorylase and GDP-fucose : glycoprotein
fucosyltransferase activity was not affected signifi-
cantly by administration of haloperidol or L-DOPA
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Fig. 4. Effect of haloperidol (H) and L-DOPA (D) administra-
tion on fucosyltransferase 1 activity in the olfactory
bulbus, striatum, thalamus, cerebellum and cortex in
vivo. C: control, η = 7 in each group.
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Fig. 3. Effect of haloperidol (H) and L-DOPA (D) administra-
tion of fucose-1-phosphate pyrophosphorylase activity
in the olfactory bulbus, striatum, thalamus, cerebellum
and cortex in vivo. C: control, η = 7 in each group.
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Fig. 5. Effect of haloperidol (H) and L-DOPA (D) administra-
tion on fucosyltransferase 2 activity in the olfactory
bulbus, striatum, thalamus, cerebellum and cortex in
vivo. C: control, η = 7 in each group.
Tab. 1. Activity pattern of the different enzymes of the anabolic fucose metabolism in the rat brain with or without dopaminergic
agonists in vitro, (χ ± SD, n = 5)
Control Haloperidol L-DOPA
(1 mmol/1)
Dopamine
Enzyme activity (nmol χ h""1 x mg"1 of protein)
Fucokinase
Fucose-1-P pyrophosphorylase
Fucosyl-transferase 1
Fucosyi-transferase 2
15.3 ± 0.9
1246 ± 97
0.17 ± 0.02
0.50 ± 0.05
15.3 + 1.0
1296 ± 201
0.16 ± 0.02
0.55 ± 0.05
16.0 ± 1.2
1305 ± 137
0.17 + 0.03
0.51 + 0.06
14.9 + 1.5
1200 ± 97
0.16 + 0.02
0.50 + 0.07
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in vivo (figs 3-5). Haioperidol selectively decreased
fucokinase activity (fig. 2) in the olfactory bulbus,
thalamus and cortex by 21%, 37%, and 39% respec-
tively (p < 0.05 in each case). A decrease' of fucoki-
nase activity in the cortex was also seen with L-DOPA
(31%, p <0.05).
Direct addition of dopaminergic agonists/antagonists
(L-DOPA, dopamine or haloperidol, 1 mmol/1 in each
case) to the enzyme assays did not alter the enzymatic
activity in vitro (tab. 1).
Discussion
Fucosylated glycoproteins in the rat brain seem to
play an essential role in memory formation (3, 8, 9).
GDP-fucose as a substrate for the different fucosyl-
transferases is mainly synthesized from L-fucose via
the fucokinase and fucose-1-phosphate pyrophos-
phorylase reaction. According to our present data,
the de novo synthesis of L-fucose starting from the
precursor fructose-6-phosphate seems to be of minor
importance in the rat brain, as the activity of the
enzyme involved in the conversion of GDP-mannose
via GDP-4-keto-6-deoxymannose to GDP-fucose was
less than 5% compared to the activity of fucokinase
or fucose-1-phosphate pyrophosphorylase in the rat
brain in vivo (unpublished data from Prof. Dr. Ch.
Bauer, Berlin). Fucosylation is influenced in vitro by
dopaminergic drugs (10, 16, 17). Our data clearly
demonstrate for the first time that the activity of
cerebral fucokinase, but not of fucose-1-phosphate
pyrophosphorylase and GDP-fucose : glycoprotein
fucosyltransferase, is influenced in vivo by haloperidol
(dopaminergic receptor antagonist) in well-circum-
scribed brain areas (figs. 2—5). Cerebral fucokinase,
therefore, may be the target enzyme of dopaminergic
drugs that regulate or modulate fucosylation of gly-
coproteins in the rat brain in vivo. In our study we
have measured enzyme activity. Therefore, a decrease
in the amount of fucokinase or inhibition of fucoki-
nase activity may explain our results. The intracellular
mechanisms mediating the dopaminergic receptor ag-
onists induced by incorporation of fucose are poorly
understood. It has been shown that glycoprotein fu-
cosylation can be stimulated in vitro by dibutyryl-
cAMP (14, 17) and phorbol esters (18). However,
direct addition of dopaminergic agonists (L-DOPA
or dopamine) and dopaminergic antagonists (halo-
peridol) to the enzyme assays did not alter the enzy-
matic activity (tab. 1). Interaction of drugs with gly-
coprotein metabolism is well known, e. g. the signifi-
cant upregulation of liver ß-galactoside a2,6-sialyl-
transferase by glucocorticoids (20). However, in our
study fucosyltransferase activity is not altered; we
observed drug-mediated significant changes only in
rat brain fucokinase activity. So far at least four
different fucosyltransferases are known, mainly de-
termined in rat liver. In the brain up to now only one
subtype of fucosyltransferase (a-1-3 fucosyltransfer-
ase) has been demonstrated (21, 22).
The unexpected finding that L-DOPA (decarboxyl-
ated in vivo to dopamine) decreases fucokinase activ-
ity (cortex, fig. 2) or has no effect (olfactory bulbus,
striatum, thalamus and cerebellum) may be due to a
receptor downregulation by receptor agonists. The
opposite effect (upregulation of dopaminergic recep-
tors) was seen after chronic treatment of rats with
dopamine receptor antagonists (19).
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